Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877)

Shanghai Junshi Biosciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,475	3,788	6,031	3,507	3,385	1,221
Trading Asset Securities	570	-	-	-	0.02	0.02
Cash & Short-Term Investments	3,045	3,788	6,031	3,507	3,385	1,221
Cash Growth	-26.97%	-37.19%	71.98%	3.59%	177.26%	-55.91%
Accounts Receivable	466.69	483.23	238.19	1,301	664.44	163.21
Other Receivables	201.57	374.01	26.18	28.05	22.84	9.7
Receivables	668.26	857.23	264.36	1,329	687.28	172.91
Inventory	567.44	538.05	599.02	484.6	343.43	180.67
Other Current Assets	305.23	387.59	322.36	524.79	283	336.67
Total Current Assets	4,586	5,571	7,216	5,845	4,699	1,911
Property, Plant & Equipment	4,060	3,809	3,020	2,801	2,377	1,851
Long-Term Investments	1,097	1,133	1,403	1,485	422.9	141.59
Other Intangible Assets	526.5	546.96	316.09	264.98	162.09	142.92
Long-Term Deferred Tax Assets	103.2	103.4	228.43	88.55	26.11	20.59
Long-Term Deferred Charges	8.02	12.6	23.24	27.79	13.24	9.23
Other Long-Term Assets	477.3	167.14	351.17	522.34	297.73	335.47
Total Assets	10,858	11,343	12,558	11,035	7,997	4,412
Accounts Payable	984.19	125.19	67.07	63.17	55.69	40.36
Accrued Expenses	232.6	1,046	1,032	1,603	826.28	302.05
Short-Term Debt	631.66	452.44	351.36	-	21.23	76.89
Current Portion of Long-Term Debt	213.79	86.96	40.39	10.6	231.11	-
Current Portion of Leases	-	35.93	43.66	34.47	25.22	13.85
Current Income Taxes Payable	35.57	17.98	-	63.08	-	-
Current Unearned Revenue	162.98	146.3	4.11	45.8	43.14	-
Other Current Liabilities	36.18	527.92	227.3	181.59	269.79	145.08
Total Current Liabilities	2,297	2,438	1,766	2,001	1,472	578.23
Long-Term Debt	1,906	1,196	839.58	490	542.22	744.9
Long-Term Leases	24.8	17.45	46.58	93.13	30.99	27.33
Long-Term Unearned Revenue	175.54	183.46	122.06	122.46	122.65	56.32
Other Long-Term Liabilities	174.64	187.15	7.5	11.5	1.28	27.15
Total Liabilities	4,578	4,022	2,782	2,719	2,170	1,434
Common Stock	985.69	985.69	982.87	910.76	872.5	784.15
Additional Paid-In Capital	15,395	15,395	15,346	11,423	8,632	4,180
Retained Earnings	-9,987	-9,060	-6,777	-4,389	-3,668	-1,999
Treasury Stock	-30.89	-26.89	-	-	-	-
Comprehensive Income & Other	-190.01	-142.07	-68.41	0.21	-9.39	12.54
Total Common Equity	6,173	7,151	9,484	7,945	5,828	2,978
Minority Interest	107.43	169.39	292.83	371.28	-0	-0
Shareholders' Equity	6,280	7,321	9,776	8,316	5,828	2,978
Total Liabilities & Equity	10,858	11,343	12,558	11,035	7,997	4,412
Total Debt	2,776	1,789	1,322	628.19	850.78	862.97
Net Cash (Debt)	268.63	2,000	4,709	2,878	2,534	357.9
Net Cash Growth	-89.88%	-57.54%	63.60%	13.58%	608.08%	-83.72%
Net Cash Per Share	0.27	2.03	5.13	3.23	3.08	0.46
Filing Date Shares Outstanding	219.29	985.01	982.87	910.76	872.5	784.15
Total Common Shares Outstanding	219.29	985.01	982.87	910.76	872.5	784.15
Working Capital	2,289	3,133	5,450	3,843	3,226	1,333
Book Value Per Share	28.15	7.26	9.65	8.72	6.68	3.80
Tangible Book Value	5,646	6,604	9,168	7,680	5,666	2,835
Tangible Book Value Per Share	25.75	6.70	9.33	8.43	6.49	3.62
Buildings	-	1,419	1,032	891.83	880.3	79.03
Machinery	-	1,921	1,514	1,419	1,247	348.52
Construction In Progress	-	1,325	1,044	801.93	415.55	1,480

Source: S&P Capital IQ. Standard template. Financial Sources.